BioVie Inc

BioVie Inc

@biovie.bsky.social

At BioVie we believe that every person deserves to live free from the limitations of aging and disease. bioviepharma.com

113 followers210 following96 posts

BioVie Inc
@biovie.bsky.social

Patients with severe symptoms of #longCOVID saw relief with 12 weeks of #Bezisterim, with the greatest relief among patients with the highest symptom burden, Dr. Penelope Markham, SVP Liver Disease and Long COVID Programs at BioVie said at #ANA2026.

healio.comBezisterim shows promise in relieving long COVID symptomsSAN DIEGO — Patients with severe symptoms of long COVID experienced relief with 12 weeks of Bezisterim therapy, according to a poster presented at the 151st Annual Meeting of the American Neurol...
BioVie Inc
@biovie.bsky.social

Participants with #Parkinsons disease with elevated baseline inflammation demonstrated statistically significant improvements in both motor and non-motor symptoms with bezisterim compared to placebo. #Neuroinflammation #Neurology #ClinicalTrials #NeuroSky

BioVie Inc
@biovie.bsky.social

Data from the trial demonstrated statistically significant improvements versus placebo across fatigue, post-exertional malaise, and objective cognitive measures in #LongCOVID patients with higher baseline symptom burden. #Neuroinflammation #Neurology #NeuroSky

BioVie Inc
@biovie.bsky.social

Participants treated with bezisterim demonstrated statistically significant improvements compared to placebo on both motor and non-motor symptoms as assessed by MDS-UPDRS Parts I, II, and III, as well as a composite endpoint comprising 15 clinically relevant measures. #ParkinsonsDisease

BioVie Inc
@biovie.bsky.social

Bezisterim appeared to improve blood based inflammatory markers of disease and a shift in a broad range of biological markers that have been shown to suggest a slowing of disease progression. #ClinicalUpdate #Neurology #Neurosky

BioVie Inc
@biovie.bsky.social

🧠 Brain fog. 🥱 Fatigue. 🤕 Cognitive impairment. For the millions living with Long COVID, these neurological and neuropsychiatric symptoms are among the most common, chronic, and debilitating. And still without a single FDA-approved treatment. #Neuroinflammation #LongCOVID

BioVie Inc
@biovie.bsky.social

#ParkinsonsDisease is the fastest-growing neurodegenerative disorder in the world. Most people think of it primarily as a movement disorder: tremors & motor symptoms. The reality is far more complex. #WorldBrainDay

BioVie Inc
@biovie.bsky.social

Parkinson's also encompasses cognitive decline, depression, sleep dysfunction, fatigue, and autonomic disruption. And underlying all of it, researchers increasingly point to the same upstream forces: chronic #neuroinflammation and brain insulin resistance.

BioVie Inc
@biovie.bsky.social

Findings from @parkinsondotorg.bsky.social's 2026 State of the Community Survey shows what matters most to ppl affected by #Parkinson's: 52% identified non-movement symptoms - sleep disturbances, mood changes & cognitive challenges - among the most pressing concerns, alongside movement symptoms.

BioVie Inc
@biovie.bsky.social

Today is #ChronicDiseaseAwarenessDay and Long COVID is a condition that demands our attention. BioVie is committed to advancing research for the millions navigating life with chronic conditions like #LongCOVID.

BioVie Inc
@biovie.bsky.social

The Phase 2 ADDRESS-LC trial evaluating bezisterim for the treatment of neurological symptoms of Long COVID is fully enrolled with topline results expected in late summer 2026.

BioVie Inc
@biovie.bsky.social

A new @jama.com study found that the number of people suffering with #longCOVID may be double current estimates. These rates translate to more than 18M Americans, and reflect the growing burden of chronic conditions following COVID-19 infection. #PASC #Neuroinflammation #BrainAwarenessMonth

BioVie Inc
@biovie.bsky.social

Parkinson's is the second most common neurodegenerative disease after Alzheimer's disease. #Inflammation and insulin resistance are believed to be key drivers of both #ParkinsonsDisease and Alzheimer's. #AlzheimersBrainAwarenessMonth #NeuroSky

BioVie Inc
@biovie.bsky.social

There are no approved treatments for #LongCOVID - yet millions are living with persistent brain fog, fatigue & cognitive impairment driven by neuroinflammation. BioVie's ADDRESS-LC trial is fully enrolled with data expected later this year. #BrainAwarenessMonth

BioVie Inc
@biovie.bsky.social

1 in 5 women and 1 in 10 men will develop Alzheimer's in their lifetime. More than 12M Americans are providing unpaid care right now, and the toll on patients, families, and caregivers is profound. #AlzheimersBrainAwarenessMonth #EndALZ

Alzheimer's Association@alzassociation.bsky.social

Take action during Alzheimer’s & Brain Awareness Month! 💜 Go purple and tell your story using #ENDALZ 🧠 Take the (re)think your brain 6-Step Challenge 🎁 Make a gift 💰 Become a fundraiser 🤝 Volunteer your time 📣 Tell Congress to act Learn more: alz.org/abam.

BioVie Inc
@biovie.bsky.social

Nearly 1M Americans are living with #ParkinsonsDisease, with ~ 90K new diagnoses every year. The burden on patients, caregivers, and the healthcare system is immense and will continue to grow. #OlderAmericansMonth

BioVie Inc
@biovie.bsky.social

#AlzheimersDisease affects 7M+ Americans and is projected to nearly double by 2060. Both are progressive and devastating, robbing people of memory, movement, & independence. And effective treatments remain out of reach for far too many patients. #Aging

BioVie Inc
@biovie.bsky.social

On #CINDAwareness Day we raise awareness & support those battling #MEcfs, #LongCOVID, #Parkinson’s, #Alzheimer's, & other Chronic Immunological and Neurological Diseases. BioVie is committed to advancing potential treatments for chronic neurological disorders. #NeuroSky 💙💚💜

BioVie Inc
@biovie.bsky.social

We stand with the millions of people living with Parkinson’s to help raise awareness, education, & hope for this progressive neurodegenerative disease that impacts movement, cognition & quality of life. #ParkinsonsAwarenessMonth #ParkinsonsResearch #HopeForPD

The Parkinson's Foundation@parkinsondotorg.bsky.social

Today is World Parkinson’s Day! 🌎 More than 10 million people worldwide are living with Parkinson’s disease, and in the United States alone, someone new is diagnosed with PD every 6 minutes. (1/2)

BioVie Inc
@biovie.bsky.social

Dopamine is one of the most common terms associated with Parkinson’s because it helps mediate smooth, controlled muscle movements. Yet when levels in the brain are too low, motions may become slow, shaky, and halted. Why? #ParkinsonsDiseaseAwarenessMonth

BioVie Inc
@biovie.bsky.social

Neuroinflammation and the resulting insulin resistance can disrupt how dopamine works in the 🧠. When the neurons lose efficient access to glucose and are starved of energy, these cells begin to falter, and the brain’s ability to control movement starts to break down. #ParkinsonsDisease #Neurosky

BioVie Inc
@biovie.bsky.social

During #ParkinsonsAwarenessMonth we honor people living with PD and their family, friends, nurses, & doctors who stand with them. BioVie is proud to support the Parkinson’s community and is committed to advancing innovative therapies for neurological disorders, including PD.

BioVie Inc
@biovie.bsky.social

To all the physicians conducting research, testing new therapies, treating patients, and providing support for people with #neurological & #neurodegenerative diseases & disorders, on #NationalDoctorsDay, we say THANK YOU. #Alz #Parkinsons #longCOVID #Medsky 🩵🩺

BioVie Inc
@biovie.bsky.social

#Parkinson’s affects ~1M people in the U.S. w/ prevalence expected to rise with aging population. Yet treatment has changed little in 50 years. Our lead drug candidate, bezisterim (NE3107), addresses the underlying neurodegeneration by targeting #inflammation that causes insulin resistance. Read ⬇️

proactiveinvestors.comBioVie targets Parkinson’s at its source with lead drug bezisterimFor decades, treatment of Parkinson’s disease has centered on replacing dopamine, the neurotransmitter whose decline drives the disease’s hallmark motor...
BioVie Inc
@biovie.bsky.social

Some of the most challenging #neurological conditions of our time share a common biology with evidence pointing to #inflammation & insulin resistance as mechanisms underlying #Alzheimer’s, #Parkinson's, & #LongCOVID. #BrainAwarenessWeek

BioVie Inc
@biovie.bsky.social

BioVie's investigational drug bezisterim targets these upstream inflammatory pathways - and is currently in Phase 2 trials for Parkinson’s & LongCOVID. The ADDRESS-LC study in adults with #LongCOVID is actively recruiting in the U.S. addresslongcovid.com #BrainWeek

BioVie Inc
@biovie.bsky.social

On #LongCOVIDAwarenessDay, we recognize the millions of people still living with the debilitating effects - including #neurological symptoms such as brain fog and fatigue - long after their initial COVID-19 infection.